XML 23 R32.htm IDEA: XBRL DOCUMENT v3.19.3
DERIVATIVE INSTRUMENTS (Tables)
9 Months Ended
Sep. 30, 2019
DERIVATIVE INSTRUMENTS [Abstract]  
Schedule of the Company's Derivative Assets and Liabilities

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Fair Value

 

 

At

 

At

 

 

September 30, 2019

 

December 31, 2018

(in thousands)

    

Assets

    

Liabilities

    

Assets

    

Liabilities

Total return swaps

 

$

 ─

 

$

 ─

 

$

1,130

 

$

 ─

Basis swaps

 

 

104

 

 

 ─

 

 

808

 

 

 ─

Interest rate caps

 

 

201

 

 

 ─

 

 

998

 

 

 ─

Interest rate swaps

 

 

 ─

 

 

324

 

 

2,674

 

 

 ─

Foreign currency forward exchange

 

 

269

 

 

 ─

 

 

187

 

 

 ─

Total carrying value of derivative instruments

 

$

574

 

$

324

 

$

5,797

 

$

 ─

 

Schedule of Derivative Notional Amounts

 

 

 

 

 

 

 

 

 

Notional Amounts

 

 

At

 

At

 

 

September 30,

 

December 31,

(in thousands)

    

2019

    

2018

Total return swaps

 

$

 ─

 

$

18,278

Basis swaps

 

 

35,000

 

 

35,000

Interest rate caps

 

 

35,000

 

 

80,000

Interest rate swaps

 

 

35,000

 

 

65,000

Foreign currency forward exchange

 

 

4,343

 

 

4,331

Total notional amount of derivative instruments

 

$

109,343

 

$

202,609

 

Schedule of notional amounts of company derivative instruments

 

 

 

 

 

 

Notional

 

 

Amounts

Balance, January 1, 2019

 

$

198,278

Impact from expirations

 

 

(46,714)

Impact from terminations

 

 

(46,528)

Impact from settlements

 

 

(36)

Balance, September 30, 2019

 

$

105,000

 

Schedule of Net Gains Recognized Recognized In Connection With Derivative Instruments

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

For the three months ended

 

For the nine months ended

 

 

September 30,

 

September 30,

(in thousands)

    

2019

    

2018

    

2019

    

2018

Total return swaps (1) 

 

$

 ─

 

$

422

 

$

(42)

 

$

2,060

Basis swaps (2)

 

 

(273)

 

 

208

 

 

(526)

 

 

715

Interest rate caps

 

 

(234)

 

 

137

 

 

(797)

 

 

612

Interest rate swaps (3) 

 

 

(441)

 

 

327

 

 

(2,717)

 

 

1,722

Foreign currency forward exchange

 

 

269

 

 

 8

 

 

89

 

 

355

Total net (losses) gains of derivative instruments

 

$

(679)

 

$

1,102

 

$

(3,993)

 

$

5,464


(1)

The accrual of net interest payments that are made in connection with TRS agreements that are reported as derivative instruments are classified as a component of “Net (losses) gains on derivatives” on the Consolidated Statements of Operations. Net cash received was $0.7 million for the three months ended September 30, 2018. Net cash received was $0.2 million and $1.9 million for the nine months ended September 30, 2019, and September 30, 2018, respectively.

(2)

The accrual of net interest payments that are made in connection with basis swaps is classified as a component of “Net (losses) gains on derivatives” on the Consolidated Statements of Operations. The net cash received was $0.1 million and $0.2 million for the three and nine months ended September 30, 2019, respectively, while the net cash paid was de minimis for the three and nine months ended September 30, 2018.

(3)

The accrual of net interest payments that are made in connection with interest rate swaps is classified as a component of “Net (losses) gains on derivatives” on the Consolidated Statements of Operations. Net cash received was de minimis for the three months ended September 30, 2019 and $0.2 million for the nine months ended September 30, 2019. Net cash received was $0.1 million and $0.3 million for the three and nine months ended September 30, 2018, respectively. During the three and nine months ended September 30, 2018, the Company also received $0.3 million to amend two interest rate swaps and recorded $0.3 million through “Other assets” on the Consolidated Balance Sheets. The amount recorded to “Net (losses) gains on derivatives” on the Consolidated Statements of Operations was de minimis.